Ethosuximide
Phenyltriazenes indicated for absence.
Indications
DOC in ABS.
Dose
℞Adult:500–1500mg/d.Peds:10–40mg/kg/d; MDF=qd.Supplied: oral only;capsules 250mg; syrup 250 mg/5-ml.
Side effects
N/V; lethargy; hiccups; H/A; rarely: eosinophilia, leukopenia, erythema multiforme, Stevens-Johnson syndrome, SLE-like syndrome. Toxic levels→ psychotic behavior.